Close
Help




JOURNAL

Clinical Medicine Reviews in Therapeutics

4,052 Journal Article Views | Journal Analytics

A Review of Pregabalin for the Treatment of Peripheral and Central Neuropathic Pain and Its Place in the Treatment of Chronic Pain

Submit a Paper



Publication Date: 19 Sep 2011

Type: Review

Journal: Clinical Medicine Reviews in Therapeutics

Citation: Clinical Medicine Reviews in Therapeutics 2011:3 325-346

doi: 10.4137/CMRT.S7398

Abstract

Pregabalin is an alpha2-gamma ligand indicated for the treatment of peripheral and central neuropathic pain. In this article, we will review the pharmacodynamics, pharmacokinetics, randomized clinical trials supporting its efficacy for a wide array of neuropathic painful conditions, and the tolerability of this medication. We will comment the main differences with gabapentin, its parent compound, both from the pharmacological and clinical perspective. Our experience in the clinical practice setting with pregabalin, its use in patients with refractory neuropathic pain and its rational use in combination regimens will also be reviewed. With all this information in mind, the place of pregabalin in the pharmacotherapy of neuropathic pain is explored, mainly through the review of recent clinical guidelines which, in fact, place pregabalin among the first-line treatments for the management of most neuropathic painful conditions.


Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)






What Your Colleagues Say About Libertas Academica
I found Clinical Medicine Insights: Case Reports very, very user friendly.  The entire process is easy and straightforward.  The corresponding author is kept updated on the progress at every point.  I am pleased to send this endorsement.
Dr Adebayo Oyedeji (Lekki Hospital, Nigeria)
More Testimonials

Quick Links


New article and journal news notification services